Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03288766 · ClinicalTrials.gov registry record
SHERLOCK 3CG™ Diamond Tip Confirmation System
A clinical trial, sponsored by C. R. Bard.
- Terminated
- Registry status
- 232
- Enrollment target
NCT03288766 is a clinical trial that was terminated before completion, run by C. R. Bard. The registered enrollment target is 232 participants.
The verdict
NCT03288766 was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- 232 participants
- Enrollment target
Study Summary
This study is a single-arm, prospective, multi-center study to assess clinical performance of the SHERLOCK 3CG™ Diamond Tip Confirmation System (TCS) with MODUS II software for confirming correct tip position of peripherally inserted central catheters (PICCs) in adult subjects with altered cardiac rhythm.
Interventions
- PROCEDURE PICC placement with SHERLOCK 3CG™ Diamond TCS with MODUS II software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2018-04-19 |
| Est. Completion | 2021-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03288766
The ClinicalTrials.gov registry entry for NCT03288766 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PICC placement with SHERLOCK 3CG™ Diamond TCS with MODUS II software is the first listed.
NCT03288766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03288766 about?
NCT03288766 is a clinical study titled "SHERLOCK 3CG™ Diamond Tip Confirmation System". This study is a single-arm, prospective, multi-center study to assess clinical performance of the SHERLOCK 3CG™ Diamond Tip Confirmation System (TCS) with MODUS II software for confirming correct tip position of peripherally inserted central catheters (PICCs) in adult subjects with altered cardiac r...
What is the current status of trial NCT03288766?
This trial is currently terminated. The enrollment target is 232 participants. The study started on 2018-04-19. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT03288766?
The interventions under investigation include: PICC placement with SHERLOCK 3CG™ Diamond TCS with MODUS II software (PROCEDURE).
Who is sponsoring clinical trial NCT03288766?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.